KLF14 was significantly downregulated in hepatocellular carcinoma (HCC), correlating with poor prognosis, and inhibits the proliferation of HCC cells by modulating cellular iron metabolism via the repression of Iron-responsive element-binding protein 2 (IRP2) [67]. The gene discussed is KLF14; the disease is hepatocellular carcinoma.